Pharmacokinetics (PK)
Understanding how drugs are absorbed, distributed, metabolized, and eliminated is critical to successful drug development. CenExel’s Pharmacokinetics (PK) research supports sponsors with precise data collection, advanced bioanalytical capabilities, and experienced clinical teams to accelerate informed development decisions across all phases of research.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Leading Pharmacokinetic Research Excellence
CenExel delivers comprehensive pharmacokinetic research solutions designed to evaluate drug exposure, bioavailability, metabolism, and elimination characteristics. Our experienced teams provide high-quality PK data that supports regulatory submissions and informed clinical development decisions.
From first-in-human studies through late-phase development, we employ rigorous sampling methodologies, advanced analytical techniques, and precise operational execution to ensure reliable and actionable pharmacokinetic outcomes.
Conditions Covered
Pharmacokinetic Studies We Support
Our PK research capabilities support a wide range of therapeutic programs and study designs.
Single Ascending Dose (SAD)
Multiple Ascending Dose (MAD)
Food Effect Studies
Drug-Drug Interaction Studies
Bioavailability Studies
Bioequivalence Studies
Mass Balance Studies
Special Population Studies
Renal Impairment Studies
Hepatic Impairment Studies
Our Approach
Why Sponsors Choose CenExel for PK
Our pharmacokinetics expertise goes beyond sample collection and analysis—we deliver scientific insight, precise bioanalytical execution, and reliable data to support informed development decisions.
01
Advanced Sampling Expertise
Experienced teams execute intensive PK sampling schedules with precision, ensuring accurate concentration-time profile data.
02
Comprehensive Study Designs
Support for SAD, MAD, food effect, interaction, and bioavailability studies across diverse therapeutic areas.
03
High-Quality Data Collection
Rigorous operational procedures ensure reliable pharmacokinetic and pharmacodynamic endpoints.
04
Accelerated Development Decisions
Actionable PK insights help sponsors optimize dosing strategies and advance programs efficiently.
Phase Coverage
Supported Trial Phases
We support pharmacokinetic studies across all phases of development, from first-in-human assessments through post-marketing investigations.
Active across all phases
Phase I
Phase II
Phase III
Phase IV
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.